These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20021961)

  • 1. [Relationship between epithelial-mesenchymal transition and basal cell-like phenotype in breast cancer].
    Wu WX; Zhang YP; Wen XW; Lu N; Tang ZY; Zhang Y; Wang Z; Wang W; Yang HJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):519-23. PubMed ID: 20021961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
    Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
    J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-cadherin and vimentin are useful basal markers in breast cancers.
    Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
    Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.
    Choi Y; Lee HJ; Jang MH; Gwak JM; Lee KS; Kim EJ; Kim HJ; Lee HE; Park SY
    Hum Pathol; 2013 Nov; 44(11):2581-9. PubMed ID: 24055090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
    Ma YH; Wang K; Li L; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
    Yamashita N; Tokunaga E; Iimori M; Inoue Y; Tanaka K; Kitao H; Saeki H; Oki E; Maehara Y
    Clin Breast Cancer; 2018 Oct; 18(5):e1003-e1009. PubMed ID: 29526677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
    He N; Wu GF; Zhao HY; Han HX
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of FOXC-2 and YB-1 in Gastric Carcinoma and Its Role in Invasion and Metastasis].
    Jin X; Qian J; Yu DJ; Guo CX; Li N; Zhu Q; Zhao Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):215-220. PubMed ID: 29737063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
    Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
    Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
    Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
    Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study.
    Sousa B; Paredes J; Milanezi F; Lopes N; Martins D; Dufloth R; Vieira D; Albergaria A; Veronese L; Carneiro V; Carvalho S; Costa JL; Zeferino L; Schmitt F
    Histol Histopathol; 2010 Aug; 25(8):963-74. PubMed ID: 20552547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer.
    Nguyen TL; Grizzle WE; Zhang K; Hameed O; Siegal GP; Wei S
    Am J Clin Pathol; 2013 Oct; 140(4):468-74. PubMed ID: 24045542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
    Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
    Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
    Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O
    Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between immunophenotype, Ki-67 index, microvascular density, Ep-CAM/P-cadherin, and MMP-2 expression in early-stage invasive ductal breast cancer.
    Niemiec JA; Adamczyk A; Małecki K; Majchrzyk K; Ryś J
    Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):550-60. PubMed ID: 22531681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.
    Kashiwagi S; Yashiro M; Takashima T; Aomatsu N; Kawajiri H; Ogawa Y; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
    Br J Surg; 2013 Mar; 100(4):490-6. PubMed ID: 23319435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.